KR880000729B1 - 아닐리노-1, 2, 3-트리아졸 유도체의 제조방법 - Google Patents
아닐리노-1, 2, 3-트리아졸 유도체의 제조방법 Download PDFInfo
- Publication number
- KR880000729B1 KR880000729B1 KR8203991A KR820003991A KR880000729B1 KR 880000729 B1 KR880000729 B1 KR 880000729B1 KR 8203991 A KR8203991 A KR 8203991A KR 820003991 A KR820003991 A KR 820003991A KR 880000729 B1 KR880000729 B1 KR 880000729B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- triazole
- methyl
- atom
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 7
- RTRKPFNNSCTWSJ-UHFFFAOYSA-N n-phenyl-2h-triazol-4-amine Chemical class C=1C=CC=CC=1NC=1C=NNN=1 RTRKPFNNSCTWSJ-UHFFFAOYSA-N 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims description 42
- 150000003839 salts Chemical class 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 150000003852 triazoles Chemical class 0.000 claims description 2
- PUYZUDWTQPBQFZ-UHFFFAOYSA-N aniline 2H-triazole Chemical class N1N=NC=C1.NC1=CC=CC=C1 PUYZUDWTQPBQFZ-UHFFFAOYSA-N 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 72
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 48
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 47
- 230000008018 melting Effects 0.000 description 26
- 238000002844 melting Methods 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- -1 n-butyl 1-4 (4-tolyl) -5-amino-1H-1, 2, 3-triazole-4-carboxylate Chemical compound 0.000 description 11
- 238000001704 evaporation Methods 0.000 description 10
- 230000008020 evaporation Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000013543 active substance Substances 0.000 description 7
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 5
- MHBXKMVSRMBFDV-UHFFFAOYSA-N methyl 5-amino-1-(4-chlorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(Cl)C=C1 MHBXKMVSRMBFDV-UHFFFAOYSA-N 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- FXKXZHRHAXHCAJ-UHFFFAOYSA-N methyl 5-amino-1-(3,4-dichlorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(Cl)C(Cl)=C1 FXKXZHRHAXHCAJ-UHFFFAOYSA-N 0.000 description 3
- UMEIJEZFBLZMBK-UHFFFAOYSA-N methyl 5-amino-1-(3,5-dichlorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC(Cl)=CC(Cl)=C1 UMEIJEZFBLZMBK-UHFFFAOYSA-N 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- RXJQVZQJLCDQOH-UHFFFAOYSA-N 5-amino-1-phenyltriazole-4-carboxylic acid Chemical class NC1=C(C(O)=O)N=NN1C1=CC=CC=C1 RXJQVZQJLCDQOH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- SIHUDRNKJJRIPV-UHFFFAOYSA-N butyl 5-(4-chloroanilino)-2-[2-(dimethylamino)ethyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.CCCCOC(=O)C1=NN(CCN(C)C)N=C1NC1=CC=C(Cl)C=C1 SIHUDRNKJJRIPV-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- MTBUEQJJMKBDKQ-UHFFFAOYSA-N methyl 5-(3,5-dichloroanilino)-2-[2-(diethylamino)ethyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC(Cl)=CC(Cl)=C1 MTBUEQJJMKBDKQ-UHFFFAOYSA-N 0.000 description 2
- VHTRBPWEAMOOJP-UHFFFAOYSA-N methyl 5-(4-chloroanilino)-2-[2-(diethylamino)ethyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C(Cl)C=C1 VHTRBPWEAMOOJP-UHFFFAOYSA-N 0.000 description 2
- XETLJFBRMNOZAG-UHFFFAOYSA-N methyl 5-(4-chloroanilino)-2-[3-(diethylamino)propyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCCN(CC)CC)N=C1NC1=CC=C(Cl)C=C1 XETLJFBRMNOZAG-UHFFFAOYSA-N 0.000 description 2
- NJVRKCHSDYUYAI-UHFFFAOYSA-N methyl 5-amino-1-(3-chloro-4-methylphenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(C)C(Cl)=C1 NJVRKCHSDYUYAI-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- AFPDDFIEGCQQBV-BTJKTKAUSA-N (z)-but-2-enedioic acid;methyl 5-(3,4-dichloroanilino)-2-[2-(diethylamino)ethyl]triazole-4-carboxylate Chemical compound OC(=O)\C=C/C(O)=O.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C(Cl)C(Cl)=C1 AFPDDFIEGCQQBV-BTJKTKAUSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- NUDFLMUUUFEBKT-UHFFFAOYSA-N 5-amino-1-(4-methoxycarbonylphenyl)triazole-4-carboxylic acid Chemical compound C1=CC(C(=O)OC)=CC=C1N1C(N)=C(C(O)=O)N=N1 NUDFLMUUUFEBKT-UHFFFAOYSA-N 0.000 description 1
- YIUIVFFUEVPRIU-UHFFFAOYSA-N 8-chlorotheophylline Chemical compound O=C1N(C)C(=O)N(C)C2=NC(Cl)=N[C]21 YIUIVFFUEVPRIU-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FYJVGCXBEOJDQS-UHFFFAOYSA-N Cl.CN(CCN1N=C(C(=N1)C(=O)OC)NC1=CC(=C(C=C1)Cl)Cl)C Chemical compound Cl.CN(CCN1N=C(C(=N1)C(=O)OC)NC1=CC(=C(C=C1)Cl)Cl)C FYJVGCXBEOJDQS-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- DTEVKYAHYNBFBQ-UHFFFAOYSA-N butyl 5-amino-1-(4-bromophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OCCCC)N=NN1C1=CC=C(Br)C=C1 DTEVKYAHYNBFBQ-UHFFFAOYSA-N 0.000 description 1
- SRMGBOYTQAOCDL-UHFFFAOYSA-N butyl 5-amino-1-(4-chlorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OCCCC)N=NN1C1=CC=C(Cl)C=C1 SRMGBOYTQAOCDL-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DCJZBLIDDBPKKI-UHFFFAOYSA-N ethyl 5-amino-1-(4-chlorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)N=NN1C1=CC=C(Cl)C=C1 DCJZBLIDDBPKKI-UHFFFAOYSA-N 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- FTFCDTUJFBLFSG-UHFFFAOYSA-N methyl 2-[2-(diethylamino)ethyl]-5-(4-methoxyanilino)triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C(OC)C=C1 FTFCDTUJFBLFSG-UHFFFAOYSA-N 0.000 description 1
- KRSMYTBNUQCFEM-UHFFFAOYSA-N methyl 2-[2-(diethylamino)ethyl]-5-(4-methoxycarbonylanilino)triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C(C(=O)OC)C=C1 KRSMYTBNUQCFEM-UHFFFAOYSA-N 0.000 description 1
- FGCWTWHDCMMSIZ-UHFFFAOYSA-N methyl 2-[2-(diethylamino)ethyl]-5-(4-nitroanilino)triazole-4-carboxylate Chemical compound COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C([N+]([O-])=O)C=C1 FGCWTWHDCMMSIZ-UHFFFAOYSA-N 0.000 description 1
- AGLUZFDVTPOUIB-UHFFFAOYSA-N methyl 2-[2-(diethylamino)ethyl]-5-(4-nitroanilino)triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(CC)CC)N=C1NC1=CC=C([N+]([O-])=O)C=C1 AGLUZFDVTPOUIB-UHFFFAOYSA-N 0.000 description 1
- VHSIUPHQUJMDCQ-UHFFFAOYSA-N methyl 5-(3,4-dichloroanilino)-2-[3-(diethylamino)propyl]triazole-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.COC(=O)C1=NN(CCCN(CC)CC)N=C1NC1=CC=C(Cl)C(Cl)=C1 VHSIUPHQUJMDCQ-UHFFFAOYSA-N 0.000 description 1
- ZMCJEAWNMKJKRL-UHFFFAOYSA-N methyl 5-(3,5-dichloroanilino)-2-[3-(diethylamino)propyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCCN(CC)CC)N=C1NC1=CC(Cl)=CC(Cl)=C1 ZMCJEAWNMKJKRL-UHFFFAOYSA-N 0.000 description 1
- AHWGAZCUGUCOPY-UHFFFAOYSA-N methyl 5-(3-chloro-4-methylanilino)-2-[2-(diethylamino)ethyl]triazole-4-carboxylate hydrochloride Chemical compound Cl.C(C)N(CCN1N=C(C(=N1)C(=O)OC)NC1=CC(=C(C=C1)C)Cl)CC AHWGAZCUGUCOPY-UHFFFAOYSA-N 0.000 description 1
- VWIJSKSOELMSQT-UHFFFAOYSA-N methyl 5-(3-chloro-4-methylanilino)-2-[2-(dimethylamino)ethyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(C)C)N=C1NC1=CC=C(C)C(Cl)=C1 VWIJSKSOELMSQT-UHFFFAOYSA-N 0.000 description 1
- AFHYKCLFGSASSG-UHFFFAOYSA-N methyl 5-(4-chloroanilino)-2-[2-(dimethylamino)ethyl]triazole-4-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1=NN(CCN(C)C)N=C1NC1=CC=C(Cl)C=C1 AFHYKCLFGSASSG-UHFFFAOYSA-N 0.000 description 1
- WDWUKHYXJCVKLA-UHFFFAOYSA-N methyl 5-amino-1-(4-bromophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(Br)C=C1 WDWUKHYXJCVKLA-UHFFFAOYSA-N 0.000 description 1
- FRAPJEAKSWPRKZ-UHFFFAOYSA-N methyl 5-amino-1-(4-fluorophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(F)C=C1 FRAPJEAKSWPRKZ-UHFFFAOYSA-N 0.000 description 1
- PLFKTDVYHSCDFX-UHFFFAOYSA-N methyl 5-amino-1-(4-methoxyphenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C(OC)C=C1 PLFKTDVYHSCDFX-UHFFFAOYSA-N 0.000 description 1
- JKFFCPICXXBWAS-UHFFFAOYSA-N methyl 5-amino-1-(4-nitrophenyl)triazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=C([N+]([O-])=O)C=C1 JKFFCPICXXBWAS-UHFFFAOYSA-N 0.000 description 1
- XELSIYWNEIGXMY-UHFFFAOYSA-N methyl 5-amino-1-phenyltriazole-4-carboxylate Chemical compound NC1=C(C(=O)OC)N=NN1C1=CC=CC=C1 XELSIYWNEIGXMY-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813134842 DE3134842A1 (de) | 1981-09-03 | 1981-09-03 | Neue anilino-1,2,3-triazol-derivate, diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung |
| DEP3134842.4 | 1981-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR880000729B1 true KR880000729B1 (ko) | 1988-04-29 |
Family
ID=6140744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR8203991A Expired KR880000729B1 (ko) | 1981-09-03 | 1982-09-03 | 아닐리노-1, 2, 3-트리아졸 유도체의 제조방법 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4505912A (enExample) |
| EP (1) | EP0073931B1 (enExample) |
| JP (1) | JPS5846073A (enExample) |
| KR (1) | KR880000729B1 (enExample) |
| AR (1) | AR231283A1 (enExample) |
| AT (1) | ATE11776T1 (enExample) |
| AU (1) | AU550948B2 (enExample) |
| CA (1) | CA1173035A (enExample) |
| DE (2) | DE3134842A1 (enExample) |
| DK (1) | DK393282A (enExample) |
| ES (1) | ES515452A0 (enExample) |
| FI (1) | FI73420C (enExample) |
| GB (1) | GB2104896B (enExample) |
| GR (1) | GR76901B (enExample) |
| IL (1) | IL66704A (enExample) |
| NO (1) | NO157101C (enExample) |
| NZ (1) | NZ201795A (enExample) |
| PT (1) | PT75493B (enExample) |
| ZA (1) | ZA826414B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR900100380A (el) * | 1989-05-20 | 1991-10-10 | Fisons Plc | Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης. |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| US9073875B2 (en) | 2012-11-20 | 2015-07-07 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2714110A (en) * | 1954-03-19 | 1955-07-26 | American Cyanamid Co | Substituted triazoles and method of preparing same |
| GB1296911A (enExample) * | 1969-02-26 | 1972-11-22 | ||
| US3900492A (en) * | 1973-05-29 | 1975-08-19 | Miles Lab | Phenyl- and (substituted)-phenyl-1,2,3-triazole-alkanoic and -alkenoic acids |
| FR2388557A2 (fr) * | 1977-04-27 | 1978-11-24 | Ici America Inc | Composition pharmaceutique tranquillisante a base de triazole substitue |
| US4431589A (en) * | 1980-12-11 | 1984-02-14 | Lilly House | Benzodiazepine compounds and their use as pharmaceuticals |
-
1981
- 1981-09-03 DE DE19813134842 patent/DE3134842A1/de not_active Withdrawn
-
1982
- 1982-08-04 AT AT82107026T patent/ATE11776T1/de not_active IP Right Cessation
- 1982-08-04 DE DE8282107026T patent/DE3262330D1/de not_active Expired
- 1982-08-04 EP EP82107026A patent/EP0073931B1/de not_active Expired
- 1982-08-20 US US06/410,008 patent/US4505912A/en not_active Expired - Fee Related
- 1982-08-31 FI FI823000A patent/FI73420C/fi not_active IP Right Cessation
- 1982-09-01 AR AR290509A patent/AR231283A1/es active
- 1982-09-01 CA CA000410567A patent/CA1173035A/en not_active Expired
- 1982-09-01 PT PT75493A patent/PT75493B/pt unknown
- 1982-09-02 ES ES515452A patent/ES515452A0/es active Granted
- 1982-09-02 NZ NZ201795A patent/NZ201795A/en unknown
- 1982-09-02 GB GB08224987A patent/GB2104896B/en not_active Expired
- 1982-09-02 JP JP57151839A patent/JPS5846073A/ja active Pending
- 1982-09-02 NO NO822969A patent/NO157101C/no unknown
- 1982-09-02 DK DK393282A patent/DK393282A/da not_active Application Discontinuation
- 1982-09-02 AU AU87952/82A patent/AU550948B2/en not_active Ceased
- 1982-09-02 GR GR69189A patent/GR76901B/el unknown
- 1982-09-02 ZA ZA826414A patent/ZA826414B/xx unknown
- 1982-09-02 IL IL66704A patent/IL66704A/xx unknown
- 1982-09-03 KR KR8203991A patent/KR880000729B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI73420C (fi) | 1987-10-09 |
| CA1173035A (en) | 1984-08-21 |
| GB2104896A (en) | 1983-03-16 |
| AU8795282A (en) | 1983-03-10 |
| FI823000L (fi) | 1983-03-04 |
| ZA826414B (en) | 1984-05-30 |
| IL66704A (en) | 1985-11-29 |
| FI73420B (fi) | 1987-06-30 |
| PT75493A (de) | 1982-10-01 |
| NZ201795A (en) | 1985-08-16 |
| DE3134842A1 (de) | 1983-03-17 |
| ES8308315A1 (es) | 1983-08-16 |
| GR76901B (enExample) | 1984-09-04 |
| ATE11776T1 (de) | 1985-02-15 |
| US4505912A (en) | 1985-03-19 |
| DK393282A (da) | 1983-03-04 |
| ES515452A0 (es) | 1983-08-16 |
| DE3262330D1 (en) | 1985-03-28 |
| JPS5846073A (ja) | 1983-03-17 |
| FI823000A0 (fi) | 1982-08-31 |
| PT75493B (de) | 1985-11-25 |
| AU550948B2 (en) | 1986-04-10 |
| EP0073931A1 (de) | 1983-03-16 |
| EP0073931B1 (de) | 1985-02-13 |
| NO822969L (no) | 1983-03-04 |
| GB2104896B (en) | 1985-05-30 |
| IL66704A0 (en) | 1982-12-31 |
| AR231283A1 (es) | 1984-10-31 |
| NO157101C (no) | 1988-01-20 |
| NO157101B (no) | 1987-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU226232B1 (en) | Substituted 3,5-diphenyl-1,2,4-triazoles, their production processes, their use as pharmaceutical metal chelators and pharamceutical compositions comprising said compositions | |
| US3349088A (en) | Therapeutically valuable 1, 2-dihyro-1, 2, 4-benzotriazine derivatives and process for preparation thereof | |
| US5354760A (en) | Crystalline Tiagabine monohydrate, its preparation and use | |
| JPWO1993011108A1 (ja) | ピペリジン誘導体及びこれを含有する医薬 | |
| BE898278A (fr) | Benzoxazines antipsychotiques. | |
| JP2767321B2 (ja) | ピペラジン誘導体及びこれを含有する医薬 | |
| US20030022904A1 (en) | Pyrazine compounds | |
| JPS62252780A (ja) | 新規なインデノチアゾ−ル誘導体及びその製造法 | |
| US4423056A (en) | 5(Aminomethyl)-4,5,6,7-tetrahydro[d]thiazole containing compositions for and medical use in treating circulatory insufficiencies | |
| GB2063874A (en) | Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
| KR880000729B1 (ko) | 아닐리노-1, 2, 3-트리아졸 유도체의 제조방법 | |
| JPH05271208A (ja) | １，４‐ベンゾチアゼピン誘導体 | |
| US4760078A (en) | Immunomodulator 1,2-dithiol-3-thione derivative composition, use method and process of producing the same | |
| US3998953A (en) | 1,3,7-Trisubstitued xanthine peripheral vasodilators | |
| DE3923675A1 (de) | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel | |
| KR920005827B1 (ko) | 벤조티아디아제핀 유도체 | |
| DE68921198T2 (de) | Benzothiadiazepin-derivate. | |
| KR100571945B1 (ko) | 2-｛3-[4-(2-ｔ-부틸-6-트리플루오로메틸피리미딘-4-일)피페라진-1-일]프로필머캅토｝피리미딘-4-올-푸마레이트 | |
| GB2171997A (en) | 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives | |
| US4593039A (en) | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols | |
| EP0329691B1 (en) | Cardiotonic imidazolylphenylpyrrol-2-ones | |
| HU198915B (en) | Process for producing new 2-thiazolidinone derivatives and pharmaceutical compositions containing them | |
| CA1198734A (en) | Three polyumorphic forms of 5-[3-(2,2,2- trifluoroethyl]guanidino)-pyrazol-1-yl)-valeramide | |
| KR20200127480A (ko) | 테네리글립틴 에디실산염 결정형 및 이의 제조방법 | |
| US4564685A (en) | Diphenylmethane compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19820903 |
|
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19870814 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19820903 Comment text: Patent Application |
|
| PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19880330 |
|
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19880711 |